Fig. 2From: Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trialEfficacy. Serial left ventricular circumferential strain values from baseline through the end of the 36-month open label extension period are shown; black lines indicate younger subjects who were on placebo and gray lines were older subjects on eplerenone during the initial 12-month double blind RCTBack to article page